Look inside at BBio

At BBio we make reliable vaccines in a high-quality production facility. The safety, efficacy and identity of each production batch is checked by the Quality Control (QC) department. Not only end products are tested, all surfaces, the water and air in the production areas are also tested at QC. This is how we measure the quality of our products.

Bilthoven Biologicals (BBio), and Batavia Biosciences (Batavia), entered into a collaboration earlier this year whereby Batavia is manufacturing viral vaccines and viral vectors in a cGMP manufacturing facility (“Amalia facility”) from BBio.

Last week the Dutch Minister of Health, Ernst Kuipers and the Indian Minister of State for Chemicals and Fertilizers, New & Renewable Energy, Bhagwanth Khuba, made a visit to Bilthoven Biologicals (BBio) to view the progress made on the Pandemic Preparedness program.

BILTHOVEN, The Netherlands, June 30, 2023 — Bilthoven Biologicals (BBio) today announced that it is one of the selected companies in Europe to be granted a pandemic preparedness contract by the European Commission. The framework agreement is aimed at pandemic preparedness including manufacturing and supply of viral vector vaccines in emergency situations in Europe.

BILTHOVEN, The Netherlands, June 30, 2023 — Bilthoven Biologicals (BBio) today announced that it is one of the selected companies in Europe to be granted a pandemic preparedness contract by the European Commission. The framework agreement is aimed at pandemic preparedness including manufacturing and supply of viral vector vaccines in emergency situations in Europe.

Maarten Manders is director Marketing and Sales at BBio. He explains how a small company from Bilthoven in the Netherlands can have a significant impact on the fight against polio worldwide.